- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
PCSK9 inhibitors have struggled to gain momentum since their US launch in 2015. As a result, PCSK9 inhibitor developers slashed prices in 2018 in order to boost uptake, according to GlobalData, a leading data and analytics company. The major barrier to the adoption of these PCSK9 inhibitors has been their high price tag, which led […]
Shell’s move on Bonga Southwest/Aparo is a major boost for Nigeria’s deepwater oil sector
Following the news (Wednesday 13 February) that Royal Dutch Shell and its partners are now set to commence the tendering process for the development of Bonga South West/Aparo (BSWA) deepwater oil project offshore Nigeria, Cao Chai, Upstream Oil & Gas Analyst at GlobalData, a leading data and analytics company, offers her view on the deepwater […]
The UK is shifting towards a cashless society as 62% of consumers use contactless
The rapid rise in contactless payments in the UK means that the UK is shifting towards a ‘cashless society’, says GlobalData, a leading data and analytics company. According to GlobalData’s 2018 Consumer Payments Insight Survey, 62% of the 4,000 respondents surveyed in the UK have a contactless card and use it for contactless payments. This […]
Western markets will not follow Japan’s lead on blockchain payments
Following the news that Japan’s Mitsubishi UFJ Financial Group is launching an open payment network built on the blockchain in 2020, Sam Murrant, Senior Payments Analyst at GlobalData offers his view: “Where it has been adopted by major banks at all, blockchain tends to be relegated to cross-border transactions as a means of cutting through […]
Five minute neck scan could predict onset of dementia but more research is needed
A study funded by the Medical Research Council, British Heart Foundation and the National Institutes of Health has revealed that an ultrasound scan of blood vessels in the neck has the potential to help doctors predict whether patients have an increased likelihood of developing vascular dementia later in life. Magdalene Crabbe, Pharma Analyst at GlobalData, […]
Restaurant Brands International is headed for success in 2019
Following Restaurant Brands International’s full year and Q4 2018 results, Lewis Towell, Consumer Analyst at GlobalData, offers his view: “2018 was a year which saw the company playing catch up with competitors, implementing all day breakfasts in Tim Hortons, rolling out delivery, and trying to expand all of its brands more aggressively using its franchising […]
Despite recent setbacks, the ophthalmology market still offers vast potential
Despite the ophthalmology market experiencing several research and development (R&D) setbacks during 2018, the launch of three new drugs highlights that the market still offers vast potential and will continue to attract substantial funds for R&D, according to GlobalData, a leading data and analytics company. A total of seven pipeline drugs were pulled from clinical […]
Total’s discovery in South Africa will re-energize stalling gas industry
Following the news (Thursday 7 February) of a major gas discovery in South Africa by Total SA, Jonathan Markham, Oil & Gas Analyst at GlobalData, a leading data and analytics company, offers his view on the find and the industry in South Africa: “Total’s announcement of the Brulpadda gas discovery off the southern coast of […]
Click & collect in the UK to grow to £10bn by 2023 but customer satisfaction lags behind home delivery
The UK click & collect market is set to rise 45.8% over the next five years to reach £9.8bn by 2023, but growth will slow as the fulfilment method matures and services offered by retailers are optimised, according to GlobalData, a leading data and analytics company. The company’s latest report ‘Click & Collect in the […]
Upstream oil and gas M&A and capital raising values totaled $47.9bn in Q4 2018
A total of 305 deals with a combined value of US$47.9bn were registered in the upstream oil and gas industry in Q4 2018, according to GlobalData, a leading data and analytics company. Of the total value, US$27.3bn was registered in mergers and acquisitions (M&A) in Q4 2018, representing a significant decrease of 41% from the […]
UK could see a dramatic shortfall in skilled workers post-Brexit
The Association of the British Pharmaceutical Industry (ABPI) has warned that the UK is in danger of losing its world-leading research and development status, backed by the country’s two biggest pharma investors, AstraZeneca and GlaxoSmithKline. Gavin Davidson, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view: “Over the past decade, the […]
Sunrise Records’ rescue of HMV faces uphill struggle against rapidly declining market
Commenting on the news that Sunrise Records is to acquire 100 HMV stores out of administration, Patrick O’Brien, UK Retail Research Director at GlobalData, offers his view: “That someone has taken on so many stores is a welcome surprise, but it is difficult to see how the market for physical music and DVDs can sustain […]
FDA bracing for another impact as the deadline to keep the government open approaches
Following the temporary halt on the US government shutdown and the approaching deadline for a compromise to keep the government open, Dr. Jesus Cuaron, Managing Pharma Analyst at GlobalData, offers his view on how this has affected the FDA, one of the most vital government agencies: “Throughout the longest federal government shutdown in US history, […]
Weak Q4 results and MS portfolio should be cause for concern for Biogen
Following Biogen’s Q4 and full year 2018 earnings call (29 January), Antoine Grey, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on the chains current challenges: “Although Biogen had positive results regarding total product sales and total revenues, compared to Q4 2017, total multiple sclerosis (MS) product revenues dropped from […]
Goldman Sachs leads GlobalData’s top 10 global M&A financial advisers league table in the Oil & Gas sector for FY 2018
Goldman Sachs has claimed the top position in the latest M&A league table of the top 10 financial advisers for the Oil & Gas sector for FY 2018, compiled by leading data analytics company GlobalData. The American bank scored the top rank with a deal value of $151.8bn, with 46 deals advised during the quarter […]
Goldman Sachs leads GlobalData’s top 20 global M&A financial adviser league table for FY2018
Goldman Sachs has maintained its number one position at the head of the latest global mergers and acquisition (M&A) financial advisers league table for FY2018, compiled by GlobalData, a leading data analytics company. The American bank advised on deals worth $1,098bn, achieving a 24.87% increase in deal value and a 27.89% growth in deal volume […]
Skadden Arps Slate Meagher & Flom tops global M&A legal advisers table for FY2018, compiled by GlobalData
Skadden Arps Slate Meagher & Flom has maintained its number one position in the latest global mergers and acquisitions (M&A) legal advisers league table for FY2018 compiled by GlobalData, a leading data and analytics company. The American law firm held the top spot again in FY2018, with 189 deals worth $546.9bn, including the second biggest […]
Development of drugs with novel MOAs marks a shift in glaucoma corporate strategy
With no new classes of drugs having been developed for the treatment of glaucoma in the last twenty years, the focus of pharmaceutical companies has begun to shift towards the development of glaucoma drugs with novel mechanisms of action (MOAs), and this trend is expected to continue to 2026. The launch of 11 new therapies […]
Significant number of drugs will launch for the treatment of age-related macular degeneration by 2026
The age-related macular degeneration (AMD) market has been dominated by big pharma companies and their pipeline candidates are ensuring a share of this lucrative market, in spite of patent expiries of their highly-priced products, according to GlobalData, a leading data and analytics company. Roche and Novartis’ Lucentis (ranibizumab) was the first anti-VEGF monoclonal antibody designed […]
Eli Lilly’s acquisition of Loxo Oncology will result in quick return of investment
Eli Lilly’s acquisition of Loxo Oncology marks the second multibillion-dollar deal in 2019 following the recent BMS and Celgene merger. Volkan Gunduz, PhD, Senior Oncology and Hematology Analyst at GlobalData, a leading data and analytics company, offers his view on the acquisition: “Eli Lilly’s choice of Loxo is highly strategic due to Loxo’s unique oncology […]